Panacea Life Sciences Holdings, Inc.
PLSH- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001552189
No open-market purchases or sales by Panacea Life Sciences Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PLSH, Q2 2026
No superinvestor reported holding PLSH at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Panacea Life Sciences Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2023 (view filing)12:21 PM ET | Sep 18 | 2 days | Buttorff LeslieCEO | PPurchase | +20.0K | $0.2365 | +$4.73K | +1.3%1.53M after | |
| Jun 12, 2023 (view filing)4:37 PM ET | Jun 9 | 3 days | Buttorff LeslieCEO | PPurchase | +3.00K | $0.4325 | +$1.30K | +0.2%1.51M after | |
| May 23, 2023 (view filing) | May 19-23 | 4 days | Buttorff LeslieCEO | PPurchase | +6.50K | $0.5115 | +$3.33K | +0.9%751.4K after | 3 lots |
| May 9, 2023 (view filing)7:11 PM ET | May 5-9 | 4 days | Buttorff LeslieCEO | PPurchase | +15.3K | $0.4671 | +$7.15K | +2.1%741.9K after | 3 lots |
| Apr 26, 2023 (view filing)7:38 PM ET | Apr 25-26 | 1 day | Buttorff LeslieCEO | PPurchase | +10.0K | $0.3838 | +$3.84K | +1.4%726.6K after | 3 lots |
| Apr 6, 2023 (view filing)8:18 PM ET | Apr 3-5 | 3 daysLate | Buttorff LeslieCEO | PPurchase | +6.70K | $0.344 | +$2.31K | +0.9%716.6K after | 3 lots |
| Mar 1, 2023 (view filing)4:21 PM ET | Feb 26-27 | 3 daysLate | Buttorff LeslieCEO | PPurchase | +4.00K | $0.1813 | +$725 | +0.6%709.9K after | 3 lots |
| Aug 29, 2022 (view filing)4:01 PM ET | Aug 26 | 3 days | Buttorff LeslieCEO | PPurchase | +15.0K | $0.1366 | +$2.05K | +2.3%660.9K after | 3 lots |
| Aug 15, 2022 (view filing)8:30 AM ET | Aug 11 | 4 days | Wert LawrenceDirector | PPurchase | +15.0K | $0.1307 | +$1.96K | +1.1%1.32M after | 3 lots |
| Aug 5, 2022 (view filing)11:17 AM ET | Aug 3-4 | 2 days | Buttorff LeslieCEO | PPurchase | +18.8K | $0.0985 | +$1.85K | +3.0%645.9K after | 9 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Panacea Life Sciences Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding PLSH in 13F filings for Q2 2026.